Go to
JCI Insight
Citations to this article
Mathias Herrmann
Published July 15, 2003
Citation Information: J Clin Invest. 2003;112(2):149-151. https://doi.org/10.1172/JCI19143.
Citation Information: J Clin Invest. 2003;112(2):149-151. https://doi.org/10.1172/JCI19143.
Abstract
Aspirin has been shown to cause a reduction in the virulence of Staphylococcus aureus–associated endocarditis. A new study reveals that salicylic acid, the major metabolite of aspirin, acts at the level of transcription to downregulate the production of fibrinogen, fibronectin, and α-hemolysin — virulence factors necessary for bacterial replication in host tissues and, now, potential therapeutic targets.
Authors
Mathias Herrmann
Citation information
Citations to this article (9)
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)